{
    "clinical_study": {
        "@rank": "72380", 
        "acronym": "TREND-HF", 
        "arm_group": [
            {
                "arm_group_label": "High intensity endurance exercise", 
                "arm_group_type": "Experimental", 
                "description": "Four weeks comprehensive cardiac rehabilitation with moderate volume high intensity endurance exercise, followed by 6 months non-supervised endurance exercise"
            }, 
            {
                "arm_group_label": "Moderate continuous endurance exercise", 
                "arm_group_type": "Active Comparator", 
                "description": "Four weeks comprehensive cardiac rehabilitation with moderate volume moderate intensity endurance exercise, followed by 6 months non-supervised endurance exercise"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether endurance exercise of either high or\n      moderate intensity can reverse structural and functional changes of the heart in patients\n      with diastolic heart failure, and to investigate which type of exercise is best in terms of\n      aerobe capacity and quality of life.\n\n      The investigators expect that high intensity endurance exercise is superior to moderate\n      intensity endurance exercise."
        }, 
        "brief_title": "Exercise Training in Treating Diastolic Heart Failure", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Heart Failure, Diastolic", 
            "Ventricular Dysfunction, Left"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Heart Failure", 
                "Ventricular Dysfunction, Left", 
                "Ventricular Dysfunction", 
                "Heart Failure, Diastolic"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study is a prospective randomized controlled intervention study comparing two active\n      arms. Eligible patients are being sampled consecutively by cardiologists, and randomized to\n      either high or moderate intensity endurance exercise. Endpoints are measured at baseline, 4\n      weeks and 7 months. The intervention is considered safe, and the study has been approved by\n      the Regional Ethics Committee (REK-midt).\n\n      This project has been financially supported by the Norwegian ExtraFoundation for Health and\n      Rehabilitation through EXTRA funds."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Sedentary lifestyle\n\n          -  Normal systolic function left ventricular ejection fraction (LVEF) < 50%\n\n          -  New York Heart Association (NYHA) class II or III\n\n          -  Diastolic dysfunction (E/\u00e9 < 15 or E/\u00e9 8-15 and N-terminal proBNP > 220pg/ml)\n\n          -  Medically stable the last 4 weeks\n\n          -  Written informed consent\n\n        Exclusion Criteria:\n\n          -  Other causes of dyspnea than diastolic heart failure\n\n          -  Personal preferences or characteristics prohibiting the person from attending\n             inpatient cardiac rehabilitation\n\n          -  Not able to perform physical exercise"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 27, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02155842", 
            "org_study_id": "2014.12327"
        }, 
        "intervention": [
            {
                "arm_group_label": "High intensity endurance exercise", 
                "intervention_name": "High intensity endurance exercise", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Moderate continuous endurance exercise", 
                "intervention_name": "Moderate continuous endurance exercise", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "exercise therapy", 
        "lastchanged_date": "June 2, 2014", 
        "location": {
            "contact": {
                "email": "cwhi@lhl-klinikkene.no", 
                "last_name": "Christina Hilmarsen, MSc"
            }, 
            "facility": {
                "address": {
                    "city": "R\u00f8ros", 
                    "country": "Norway"
                }, 
                "name": "LHL Klinikkene"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Norway"
        }, 
        "number_of_arms": "2", 
        "official_title": "High Versus Moderate Intensity Endurance Exercise Training in Treating Diastolic Heart Failure", 
        "overall_contact": {
            "email": "cwhi@lhl-klinikkene.no", 
            "last_name": "Christina Hilmarsen, Msc"
        }, 
        "overall_official": {
            "affiliation": "Norwegian University of Science and Technology", 
            "last_name": "Ulrik Wisl\u00f8ff, phd prof", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Norway:National Committee for Medical and Health Research Ethics", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Cardiopulmonary exercise test", 
                "measure": "Change in aerobic capacity measured as oxygen consumption", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 7 months"
            }, 
            {
                "description": "Ultrasound", 
                "measure": "Change in diastolic filling pressure measured as E/\u00e9", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 7 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02155842"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Feasibility, measured as attrition rate and compliance with exercise", 
                "safety_issue": "No", 
                "time_frame": "Baseline to 7 months"
            }, 
            {
                "measure": "Blood-risk profile, measured as changes in cholesterol, hemoglobin, N terminal-proBNP", 
                "safety_issue": "No", 
                "time_frame": "Baseline to 7 months"
            }, 
            {
                "description": "Ultrasound", 
                "measure": "Cardiac function measured as volume, size, efficacy", 
                "safety_issue": "No", 
                "time_frame": "Baseline to 7 months"
            }, 
            {
                "description": "Ultrasound", 
                "measure": "Arterial function measured as blood-vessel elasticity", 
                "safety_issue": "No", 
                "time_frame": "Baseline to 7 months"
            }, 
            {
                "description": "Self-reported questionnaires", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "Baseline to 7 months"
            }, 
            {
                "description": "Self-reported questionnaire, diary, activity monitoring device", 
                "measure": "Changes in everyday activity level", 
                "safety_issue": "No", 
                "time_frame": "Baseline to 7 months"
            }
        ], 
        "source": "Norwegian University of Science and Technology", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "LHL-klinikkene, R\u00f8ros", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "LHL-klinikkene, Feiring", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Norwegian University of Science and Technology", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}